References
  1. Kusumoto FM, Schoenfeld MH, Wilkoff BL, Berul I, Birgersdotter-Green UM, Carrillo R, et al. 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14:e503-e551
  2. Bongiorni MG, Kennergren C, Butter C, Deharo JC, Kutarski A, Rinaldi CA, et al. The European Lead Extraction ConTRolled (ELECTRa) study: a European Heart Rhythm Association (EHRA) Registry of Transvenous Lead Extraction Outcomes. Eur Heart J. 2017;38:2995-3005.
  3. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, et al. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE registry. Circulation. 2010; 19;122:1553-1561.
  4. Agarwal SK, Kamireddy S, Nemec J, Voigt A, Saba S. Predictors of complications of endovascular chronic lead extractions from pacemakers and defibrillators: a single-operator experience. J Cardiovasc Electrophysiol. 2009;20:171-175.
  5. Nowosielecka D, Jacheć W, Polewczyk A, Tułecki Ł, Tomków K, Stefańczyk P, et al. Transesophageal echocardiography as a monitoring tool during transvenous lead extraction – does it improve procedure effectiveness? J Clin Med. 2020; 8:1382
  6. Segreti L, Giannotti Santoro M, Di Cori A, Zucchelli G, Viani S, De Lucia R, et al. Utility of risk scores to predict adverse events in cardiac lead extraction. Expert Rev Cardiovasc Ther. 2018;16:695-705
  7. Jacheć W, Polewczyk A, Polewczyk M, Tomasik A, Kutarski A. Transvenous Lead Extraction SAFeTY Score for Risk Stratification and Proper Patient Selection for Removal Procedures Using Mechanical Tools. J Clin Med. 2020;9 pii: E361. doi: 10.3390/jcm9020361.
  8. Lewis RK, Pokorney SD, Greenfield RA, Hranitzky PM, Hegland DD, Schroder JN, et al. Preprocedural ECG-gated computer tomography for prevention of complications during lead extraction. Pacing Clin Electrophysiol 2014;37:1297-1305.
  9. Lo R, D’Anca M, Cohen T, Kerwin T. Incidence and prognosis of pacemaker lead-associated masses: a study of 1,569 transesophageal echocardiograms. J Invasive Cardiol 2006;18:599–601.
  10. Downey BC, Juselius WE, Pandian NG , Mark Estes III NA, Link MS. Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiography. Pacing Clin Electrophysiol 2011;34:679–683.
  11. Hilberath JN, Burrage PS, Shernan SK, Varelmann DJ, Wilusz K, Fox JA, et al. Rescue transoesophageal echocardiography for refractory haemodynamic instability during transvenous lead extraction. Eur Heart J Cardiovasc Imaging. 2014;15:926-932.
  12. Oestreich BA, Ahlgren B, Seres T,  Zipse MM, Tompkins C, Varosy PD, et al. Use of Transesophageal Echocardiography to Improve the Safety of Transvenous Lead Extraction. JACC Clin Electrophysiol. 2015;1:442-448.
  13. Bongiorni MG, Di Cori A, Soldati E, Zucchelli G, Arena G, Segreti L, et al. Intracardiac echocardiography in patients with pacing and defibrillating leads: A Feasibility Study. Echocardiography 2008;25:632-638.
  14. Narducci ML, Pelargonio G, Russo E, Marinaccio L, Di Monaco A, Perna F, et al. Usefulness of intracardiac echocardiography for the diagnosis of cardiovascular implantable electronic device-related endocarditis. J Am Coll Cardiol. 2013;61:1398–1405.
  15. Dalal A, Asirvatham SJ, Chandrasekaran K, Seward JB, Tajik T. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J Am Soc Echocardiogr 2002;15:1027–1028.
  16. Nowosielecka D, Polewczyk A, Jacheć W, Tułecki Ł, Tomków K, Stefańczyk P, et al. A new approach to the continuous monitoring of transvenous lead extraction using transesophageal echocardiography-analysis of 936 procedures. Echocardiography. 2020;37:601-611.
  17. Strachinaru M, Kievit CM, Yap SC, Hirsch A, Geleijnse ML, Szili-Torok T. Multiplane/3D transesophageal echocardiography monitoring to improve the safety and outcome of complex transvenous lead extractions. Echocardiography. 2019;36:980-986.
  18. Nowosielecka D, Polewczyk A, Jacheć W, Tułecki Ł, Kleinrok A, Kutarski A. Echocardiographic findings in patients with cardiac implantable electronic devices- analysis of factors predisposing to lead-associated changes. Clin Physiol Funct Imaging. 2020;18. Online ahead of print.
  19. Kutarski A, Czajkowski M, Pietura R, Obszanski B, Polewczyk A, Jachec W, et al. Effectiveness, safety, and long-term outcomes of non-powered mechanical sheaths for transvenous lead extraction. Europace. 2018;20:1324-1333
  20. Wilkoff BL, Love CJ, Byrd CL, Bongiorni MG, Carrillo RG, Crossley GH 3rd, et al. Transvenous Lead Extraction: Heart Rhythm Society Expert Consensus on Facilities, Training, Indications, and Patient Management. Heart Rhythm, 2009; 6: 1085-1104.
  21. Bongiorni MG, Burri H, Deharo JC,  Starck C, Kennergren C, Saghy L, et al. 2018 EHRA expert consensus statement on lead extraction: recommendations on definitions, endpoints, research trial design, and data collection requirements for clinical scientific studies and registries: endorsed by APHRS/HRS/LAHRS. Europace. 2018 1;20:1217
  22. Bongiorni MG, Soldati E, Zucchelli G, Di Cori A, Segreti L, De Lucia R, et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur Heart J. 2008;29:2886-1893
  23. Golzio PG, Errigo D, Peyracchia M, Gallo E, Frea S, Castagno D, et al. Prevalence and prognosis of lead masses in patients with cardiac implantable electronic devices without infection. J Cardiovasc Med. 2019,20:372–378